The relationship of Chlamydia trachomatis inclusion-forming units in quantitative culture to clinical manifestations and inflammation in urogenital disease was assessed in 1179 patients attending a sexually transmitted diseases clinic. In women, greater inclusion-forming unit counts were associated with cervical mucopus (3000 vs. 450 ifu), amount and character of cervical discharge, у30 polymorphonuclear cells (PMNL) per high-power field (hpf) on Gram stain (2050 vs. 320 ifu), and diagnoses of mucopurulent cervicitis (MPC; 2550 vs. 300 ifu) and pelvic inflammatory disease (PID; 3000 vs. 578 ifu). In men, greater inclusion-forming unit counts were associated with urethral discharge (85 vs. 44 ifu), amount and character of discharge, and у10 PMNL/hpf (95 vs. 50 ifu). These associations persisted on multivariate analysis. Thus, chlamydial replication is associated with MPC and PID in women, urethritis in men, and inflammation in both. Since infections with high inclusion counts may be the most transmissible, identification and treatment of patients with these chlamydia-associated syndromes is important in control programs.
Understanding the relationship of Chlamydia trachomatis urogenital disease to clinical manifestations and acute inflammation is important in better understanding the epidemiology and pathogenesis of these infections. Clinical manifestations caused by C. trachomatis likely represent the combined effects of direct chlamydial replication and host inflammatory responses [1] . The relationship between active chlamydial replication and clinical manifestations can be assessed by using the number of inclusion-forming units produced in cell tissue culture as a quantitative measure of the number of viable infectious elementary bodies in genital secretions. The number of inclusion-forming units in culture may also be regarded as a surrogate for infectivity or transmissibility [2] . By use of a large database that allowed for adjustment of potential confounding factors, we conducted a cross-sectional study to assess the relationship between chlamydial inclusion-forming units in quantitative cultures with clinical manifestations and degree of acute inflammation in urogenital chlamydial infection.
Methods
Patient population and data collection. The study population consisted of 671 women and 933 heterosexual men who had a culture-documented urogenital chlamydial infection at the Public Health, Seattle and King County Sexually Transmitted Diseases Clinic from May 1995 through December 1999. Study data were from the clinic's computerized database, which has gender-specific standardized medical record forms. Persons with coexisting gonococcal infection or infections due to nonfusing C. trachomatis phenotypes were excluded as a means of addressing potential confounders that may influence the relationship of chlamydial inclusion-forming unit counts to clinical manifestations [3, 4] . Patients with repeat infections with the same serovar within 1 month or mixed serovar infections were excluded, because their inclusion would violate independence in the multivariate analysis.
Source and characterization of C. trachomatis isolates. The methods used for specimen collection, isolation of C. trachomatis, identification and quantification of inclusions, and serotyping have been described in detail elsewhere [2, 5] . In brief, specimens were collected, were stored in chlamydia transport medium at 4ЊC, and were transported within 24 h to the laboratory. Each specimen was inoculated onto McCoy cells and overlaid with growth medium. Chlamydial inclusions were detected with a genus-specific antichlamydial lipopolysaccharide monoclonal antibody conjugated with fluorescein. The average inclusion count per 100-mL well was determined by counting 3 fields and multiplying the average count by a predetermined conversion factor based on magnification with a Zeiss epifluorescence microscope. Inclusions were counted individually in cultures with !100 inclusions. All technicians who determined inclusion-forming unit counts used the same standardized method [5] . For serotyping, chlamydial strains were cultured in 96-well microtiter plates and were serotyped by using subspecies-and serovar-specific monoclonal antibodies. Serovars were additionally grouped as B complex (serovars B, Ba, D, Da, D Ϫ , E, L1, L2, and L2a), intermediate group FG (serovars F and G), and C complex (serovars A, C, H, I, Ia, I
Ϫ , J, K, and L3) [6] [7] [8] . The nonfusing chlamydial phenotype was detected visually by observing inclusion morphology during serotyping [5] .
Statistical analysis. Statistical analyses were conducted by using Stata (release 6.0) software. Separate analyses were done for women and men. We used the Wilcoxon rank sum (Mann-Whitney U) or Kruskal-Wallis nonparametric tests to assess differences in median inclusion-forming unit counts between those with and without a given clinical manifestation. Multivariate regression analysis was used to assess the relationship between inclusion-forming unit count and clinical manifestations while controlling for the covariates age, race, chlamydial serovar class, and oral contraceptive use, which were considered to be potential predictors of inclusionforming unit count a priori. Inclusion-forming unit counts were log transformed (base 10). A regression coefficient of 1.0 represents a 1-log difference in inclusion-forming unit count (e.g., from 10 to 100). A positive coefficient represents an inclusion-forming unit count higher than that of the reference group. Similarly, a negative coefficient represents a lower inclusion-forming unit count.
Results
Study population characteristics. Inclusion criteria were met by 479 women and 700 heterosexual men. The mean ages (‫ע‬SD) of women and men were years and years, 22.2 ‫ע‬ 6.0 26.5 ‫ע‬ 7.0 respectively. Of women, 34% were white, 32% were black, and 34% were of other races; of men, 24% were white, 52% were black, and 24% were of other races. Oral contraceptives were used by 12% of women. Prior chlamydial infection was reported by 14% of women and 17% of men. Women (89%) and men (86%) were infected predominately with chlamydial serovars D, E, F, Ia, and J. Similar proportions of women and men were infected with serovar classes B complex (48% vs. 53%, respectively), intermediate group FG (23% vs. 21%, respectively), and C complex (29% vs. 26%, respectively). Median inclusion-forming unit counts were 625 in women and 76 in men.
Relationship of C. trachomatis inclusion-forming unit count to clinical manifestations and acute inflammation in women.
By univariate analysis, greater median inclusion-forming unit counts were associated with the presence of the following symptoms, clinical signs, or laboratory findings (table 1): complaint of intermenstrual bleeding (3000 vs. 468 ifu;
), cervical P p .001 friability (950 vs. 375 ifu;
), cervical mucopus (3000 P p .029 vs. 450 ifu;
), cervical motion tenderness (3000 vs. 600 P ! .001 ifu;
), uterine fundal tenderness (5095 vs. 575 ifu; P p .027 ), and у30 polymorphonuclear leukocytes (PMNL) P p .006 per high-power field (hpf) on Gram-stained smear (2050 vs. 320 ifu;
). Inclusion-forming unit counts increased with P ! .001 greater quantity of cervical exudate, more purulent cervical exudate, and greater numbers of PMNL per hpf on Gramstained smear ( , all comparisons). Inclusion-forming P ! .001 unit counts were also greater in women diagnosed with mucopurulent cervicitis (MPC; 2550 vs. 300 ifu; ) or pelvic P ! .001 inflammatory disease (PID; 3000 vs. 578 ifu;
). After P p .009 controlling for age, race, chlamydial serovar class, and oral contraceptive use, all clinical and laboratory findings significant on univariate analysis, except cervical friability ( ), re-P p .11 mained significantly associated with inclusion-forming unit count on multivariate analysis. In table 1, increasing inclusionforming unit counts are noted by a positive coefficient, equivalent to a log 10 difference in number of inclusion-forming units.
Because more chlamydial inclusions were associated with both MPC ( ) and PID ( ) clinical diagnoses, n p 174 n p 21 analyses restricted to women without MPC ( ) were pern p 306 formed to assess the direct relationship of inclusion-forming unit count to a diagnosis of PID ( ). In women without n p 15 MPC, greater median inclusion-forming unit counts were associated with a PID diagnosis (9000 vs. 258 ifu;
) and P p .006 with uterine fundal tenderness (7395 vs. 250 ifu;
) and P p .008 cervical motion tenderness (9000 vs. 260 ifu;
). P p . ). Inclusion-forming unit counts increased P ! .001 with greater quantity of urethral discharge ( ) and P p .009 greater numbers of PMNL per hpf on Gram-stained smear ( ). After controlling for age, race, and chlamydial se-P ! .001 rovar class, all clinical and laboratory findings significant on univariate analysis remained significantly associated with inclusion-forming unit count on multivariate analysis (table 2) .
Discussion
We demonstrated strong associations between increased number of inclusions in C. trachomatis culture and most clinical signs and laboratory findings suggestive of urogenital infection with this organism in women and men. These associations, except for cervical friability, persisted after controlling for age, race, chlamydial serovar class, and oral contraceptive use. Previously, sex, age, race, and the infecting chlamydial serovar in women with urogenital chlamydia were associated with inclusion-forming unit count [2, 3] . Eckert et al. [2] reported that inclusion counts were highest in young white females infected with B-class serovars. Barnes et al. [3] reported that youth, white race, and oral contraceptive use were independent determinants of a high inclusion-forming unit count in women without concurrent gonorrhea. Chlamydial infections in men due to nonfusing C. trachomatis phenotypes were associated with lower inclusion-forming unit counts than were infections with wild- [4] . Controlling for these factors in our study was important in assessing the relationship of inclusion-forming unit count to clinical manifestations and acute inflammation.
The few prior studies that assessed the relationship of inclusion-forming unit count to clinical or laboratory findings of cervical chlamydial infection have reported contradictory results [3, 9, 10] . However, these studies did not always control for epidemiologic factors that may have confounded the relationship between number of inclusion-forming units and symptoms and signs of chlamydial infection. In addition, a variety of factors related to specimen collection (e.g., type of swab used or depth of swab insertion), transport time and method, and culture technique all influence the number of inclusion-forming units in culture. These factors likely differ between study sites and perhaps over time. Hobson et al. [9] reported that inclusion counts were significantly higher in women with cervical mucopus. However, other reports did not confirm that association [3, 10] . The relationship of inclusion-forming unit count to specific clinical and laboratory findings of urethral chlamydial infection in heterosexual men has not been reported to our knowledge. Mallinson et al. [10] limited their analyses to the relation of inclusion-forming unit counts to the clinical diagnosis of urethritis in men, not to specific clinical manifestations or markers of acute inflammation.
In our study, most symptoms assessed, except for dysuria in men and intermenstrual bleeding in women, were not associated with increased inclusion-forming unit counts. It is unclear why dysuria in men was associated with increased inclusion-forming units while no difference was detected in inclusion-forming unit counts between men with and without urethral discharge. It is possible that, since dysuria may be a more noticeable symptom than scant urethral discharge, men with dysuria present earlier in the course of infection for evaluation when higher inclusion counts may be present. A similar explanation may apply to women with intermenstrual bleeding. Of the clinical signs not associated with increased inclusion counts, adnexal and testicular tenderness were uncommon examination findings, and it is possible that our sample size was insufficient to detect sigDownloaded from https://academic.oup.com/jid/article-abstract/184/10/1350/833919 by guest on 21 January 2019 nificant differences in inclusion-forming unit counts when these signs were present. This study has some limitations. The study population represents a high-risk group of patients at a sexually transmitted diseases clinic and may not be representative of persons in other clinical settings. Although we used a large sample size and standardized techniques for specimen collection, transport, and culture to minimize variation in inclusion-forming units attributable to these factors, some variation likely occurred. Other factors not accounted for in our study that may influence the number of chlamydial inclusions should be noted. It is possible that subjects with repeated exposure to C. trachomatis may have acquired partial immunity and may shed fewer viable organisms, leading to lower inclusion-forming unit counts upon repeat infections (an argument made by some as to why older women with urogenital chlamydia have lower inclusion-forming unit counts [3] ). In our study population, a history of prior chlamydial infection was independently associated with inclusion-forming unit count in men, but not women, and the inclusion-forming unit count, contrary to speculation, was actually higher in men who reported previous chlamydial infection (data not shown). The time period between acquisition of chlamydia and clinical presentation, which was not known, may influence inclusion-forming unit counts if those with a longer duration of infection have lower inclusion-forming unit counts. Finally, misclassification bias could have influenced clinical findings as clinical data were collected by multiple clinicians, although the influence was likely minimal as clinicians used the same standardized definitions in scoring clinical findings, and most clinical findings were strongly associated with inclusion-forming unit counts ( ). P ! .01
In conclusion, increased numbers of inclusions produced in culture were associated with acute inflammation and most clinical signs of urogenital chlamydial infection. Specifically, increased inclusion counts were associated with the presence, amount, and purulence of cervical exudate in women and urethral discharge in men, as judged by either examination or PMNL count, and also with the diagnoses of MPC and PID in women. Thus, the data suggest that active chlamydial replication, as manifested by high inclusion counts, is associated with MPC and PID (independent of MPC) in women, urethritis in men, and acute local inflammatory response in both. An increased inclusion-forming unit count, representative of increased numbers of viable organisms being shed and isolated in culture, may indicate heightened potential for transmission in persons with clinical signs of urogenital infection. From a prevention perspective, it is of considerable importance to identify and treat women and men with acute chlamydial syndromes such as cervicitis and urethritis as they may be the most likely to transmit infection.
